Universal Health Services Inc. Cl B 0.58% $12.1B ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has published its 2024 ...

In a report released yesterday, Anne Samuel from J.P. Morgan maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $232.00. The company’s shares closed ...

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the ...

2025--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 ...

BTIG analyst David Larsen downgraded Iqvia (IQV) to Neutral from Buy without a price target The firm says clinical research organization commentary from a large healthcare conference in January ...

IQVIA Technologies helps organizations realize the power of human data science, analytics and technology to transform decision-making across clinical, compliance, real world and commercial operations.

RESEARCH TRIANGLE PARK, N.C. – February 4, 2025 – IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its ...

Did you analyze how IQVIA Holdings (IQV) fared in its international operations for the quarter ending December 2024? Given the widespread global presence of this clinical testing company ...